Fosun Health

Founded in 2010, Shanghai Fosun Health Technology (Group) Co., Ltd. ("Fosun Health" or the "Group") is a majority-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 600196.SH; 02196.HK). Over more than a decade of development, Fosun Health has evolved into an integrated online-and-offline medical service platform centered in the Greater Bay Area, with general hospitals as its core operations and specialty care services in oncology, orthopedics, and other clinical disciplines.

Fosun Health is committed to becoming a "trusted, innovative, and high-quality healthcare partner". It continuously advances medical specialty capabilities, promotes integrated operations across its medical institutions, bridges in-person and digital care, extends primary care coverage, delivers multi-tiered specialty services, and innovatively builds a whole-life-cycle health management system.

As of June 30, 2026, Fosun Health operates and holds majority control in 18 medical institutions, including general hospitals, specialty hospitals, clinics, and independent clinical laboratories, with a total of more than 6,470 beds and 8 internet hospital operating licenses. Its affiliated institutions include 70 key specialties at the provincial and municipal levels, and 7 hospitals hold GCP accreditation. Several institutions are designated hospitals under the "Hong Kong and Macao Drug and Medical Device Access" program, through which nearly 100 innovative international drugs and medical devices have been introduced.

Fosun Health is accelerating its global strategic expansion into South Asia, Southeast Asia, and the Middle East—actively developing markets in Indonesia, Bangladesh, Vietnam, Mongolia, Hong Kong, and Macao—to build an open, stable, and professional international medical collaboration network. Concurrently, Fosun Health continues to strengthen synergies between healthcare services and insurance, with its affiliated medical institutions having partnered with over 65 domestic and international insurers.

Driven by strong capabilities and a commitment to industry excellence, Fosun Health ranks 2nd on the Alibi GAHA "Top 100 Private Hospital Groups in China," maintaining its top-three standing for four consecutive years. Nine of its member hospitals earned places on the "Top 500 Private Benchmark Hospitals," led by Fosun Hospital Foshan, which has secured the No. 1 spot nationwide for eight consecutive years (2018–2025). On the international stage, Fosun Health and its subsidiary hospitals garnered multiple honors at the 2026 Global Health Awards—including "Oncology Service Provider of the Year in Asia Pacific," "TCM Hospital of the Year Asia Pacific," and "Hospital of the Year China"—highlighting its outstanding strength in integrated healthcare and clinical services.